Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper

PURPOSE: To compare the outcome of photorefractive keratectomy (PRK) and complications in patients treated with either loteprednol etabonate 0.5% gel or prednisolone acetate 1% suspension and fluorometholone (fml) 0.1% suspension. SETTING: John A Moran Eye Center, University of Utah, Salt Lake City,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mifflin, Mark D, Betts, Brent S, Frederick, P Adam, Feuerman, Jason M, Fenzl, Carlton R, Moshirfar, Majid, Zaugg, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476723/
https://www.ncbi.nlm.nih.gov/pubmed/28652697
http://dx.doi.org/10.2147/OPTH.S138272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476723/
https://www.ncbi.nlm.nih.gov/pubmed/28652697
http://dx.doi.org/10.2147/OPTH.S138272

Ejemplares similares